Simultaneous Quantitation of N-nitrosamines and NDSRI in API and Formulation by Using a DUISTM Ionization Source in LC-MS/MS

Applications | 2025 | ShimadzuInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Shimadzu
Downloadable PDF for viewing
 

Similar PDF

Simultaneous quantitation of N-nitrosamines and NDSRI in API and formulation by using a DUIS ionization source in LC-MS/MS
Highly sensitive method for the determination of 12 nitrosamine impurities in multiple ARBs, the class of sartan drug formulations
Determination of Nitrosamine Impurities and NDSRI in Anti-diabetic Drugs on Shimadzu LCMS-8060NX
HRAM LC-MS method for the determination of nitrosamine impurities in drugs